193 related articles for article (PubMed ID: 32037194)
1. Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.
Eva LJ; Sadler L; Fong KL; Sahota S; Jones RW; Bigby SM
Gynecol Oncol; 2020 May; 157(2):450-455. PubMed ID: 32037194
[TBL] [Abstract][Full Text] [Related]
2. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.
Nitecki R; Feltmate CM
Curr Probl Cancer; 2018 Sep; 42(5):476-485. PubMed ID: 30093165
[TBL] [Abstract][Full Text] [Related]
4. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
[TBL] [Abstract][Full Text] [Related]
6. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
7. Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node.
Lindell G; Näsman A; Jonsson C; Ehrsson RJ; Jacobsson H; Danielsson KG; Dalianis T; Källström BN; Larson B
Gynecol Oncol; 2010 May; 117(2):312-6. PubMed ID: 20138657
[TBL] [Abstract][Full Text] [Related]
8. The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinoma.
Kowalewska M; Szkoda MT; Radziszewski J; Ptaszynski K; Bidzinski M; Siedlecki JA
Int J Gynecol Cancer; 2010 Apr; 20(3):434-7. PubMed ID: 20375810
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden.
Larsson GL; Helenius G; Andersson S; Elgh F; Sorbe B; Karlsson MG
Int J Gynecol Cancer; 2012 Oct; 22(8):1413-9. PubMed ID: 23013732
[TBL] [Abstract][Full Text] [Related]
10. HPV status and favourable outcome in vulvar squamous cancer.
Wakeham K; Kavanagh K; Cuschieri K; Millan D; Pollock KG; Bell S; Burton K; Reed NS; Graham SV
Int J Cancer; 2017 Mar; 140(5):1134-1146. PubMed ID: 27864932
[TBL] [Abstract][Full Text] [Related]
11. Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer.
Carreras-Dieguez N; Saco A; Del Pino M; Pumarola C; Del Campo RL; Manzotti C; Garcia A; Marimon L; Diaz-Mercedes S; Fuste P; Rodrigo-Calvo MT; Vega N; Torné A; Rakislova N
Histopathology; 2023 Apr; 82(5):731-744. PubMed ID: 36593525
[TBL] [Abstract][Full Text] [Related]
12. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
[TBL] [Abstract][Full Text] [Related]
13. Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination.
Rasmussen CL; Thomsen LT; Aalborg GL; Kjaer SK
Gynecol Oncol; 2020 Jun; 157(3):664-670. PubMed ID: 32276790
[TBL] [Abstract][Full Text] [Related]
14. "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".
Rakislova N; Clavero O; Alemany L; Saco A; Quirós B; Lloveras B; Alejo M; Pawlita M; Quint W; Del Pino M; de Sanjose S; Ordi J;
Int J Cancer; 2017 Dec; 141(12):2517-2527. PubMed ID: 28815579
[TBL] [Abstract][Full Text] [Related]
15. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
Clancy AA; Spaans JN; Weberpals JI
Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma.
Schuurman MS; van den Einden LC; Massuger LF; Kiemeney LA; van der Aa MA; de Hullu JA
Eur J Cancer; 2013 Dec; 49(18):3872-80. PubMed ID: 24011936
[TBL] [Abstract][Full Text] [Related]
17. Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.
Swarts DRA; Voorham QJM; van Splunter AP; Wilting SM; Sie D; Pronk D; van Beurden M; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM; Bleeker MCG
Cancer Med; 2018 Sep; 7(9):4542-4553. PubMed ID: 30030907
[TBL] [Abstract][Full Text] [Related]
18. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
[No Abstract] [Full Text] [Related]
19. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?
Alonso I; Fusté V; del Pino M; Castillo P; Torné A; Fusté P; Rios J; Pahisa J; Balasch J; Ordi J
Gynecol Oncol; 2011 Sep; 122(3):509-14. PubMed ID: 21652058
[TBL] [Abstract][Full Text] [Related]
20. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
